Covetrus Capital Markets Day
by David E Shaw
As board chair of Covetrus and as co-founder and chair of Vets First Choice, I’m pleased to report that the combination of Vets First Choice and Henry Schein Animal Health to create Covetrus Inc closes this week. We hosted a Covetrus capital markets day on February 4 to present the company to the investor world.
The new company will be a leader in the ~$150 billion global animal health market with game-changing technology to improve veterinary medicine. Covetrus launches with a staff of more than 5000 people serving some 100,000 veterinary practices in 25 countries. Proforma combined revenue for 2018e is approximately $4 billion.
Local Maine news coverage can be viewed HERE
News about Covetrus being added to the S&P 400 can be read HERE
Materials presented at the February 4 event are available HERE
And a recording of the webcast can be viewed HERE